CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | Mattessich Antony C. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2022-06-13 | Johnson David Michael Director | Purchase | +7,000 | $13.99 | $98K | 10,000 |
| 2022-06-13 | Johnson David Michael Director | Purchase | +7,000 | $13.99 | $98K | 10,000 |
| 2022-06-13 | Johnson David Michael Director | Purchase | +20,000 | $13.99 | $280K | 30,000 |
| 2022-06-10 | Johnson David Michael Director | Purchase | +3,000 | $15.04 | $45K | 3,000 |
| 2022-06-10 | Johnson David Michael Director | Purchase | +3,000 | $15.04 | $45K | 3,000 |
| 2022-06-10 | Johnson David Michael Director | Purchase | +10,000 | $15.04 | $150K | 10,000 |
| 2021-11-02 | Matrix Capital Management Company, LP 10% owner | Conversion | +2,327,870 | 2,327,870 | ||
| 2021-11-02 | Matrix Capital Management Company, LP 10% owner | Purchase | +1,785,000 | $14.00 | $25.0M | 4,112,870 |
| 2021-11-02 | Matrix Capital Management Company, LP 10% owner | Conversion · Series E Convertible Preferred Stock | −2,327,870 | 0 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion | +2,275,827 | 2,275,827 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Purchase | +693,525 | $14.00 | $9.7M | 2,969,352 |
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion | +54,065 | 54,065 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Purchase | +16,475 | $14.00 | $231K | 70,540 |
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion · Series D-1 Convertible Preferred Stock | −1,650,676 | 0 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion · Series D-2 Convertible Preferred Stock | −373,606 | 0 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion · Series E Convertible Preferred Stock | −251,545 | 0 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion · Series D-1 Convertible Preferred Stock | −39,214 | 0 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion · Series D-2 Convertible Preferred Stock | −8,876 | 0 | ||
| 2021-11-02 | Medicxi Ventures Management (Jersey) Ltd 10% owner | Conversion · Series E Convertible Preferred Stock | −5,975 | 0 |
Page 10 of 11 · 219 trades